Sign in
CompletedNo phase

Mechanisms of Upper Airway Obstruction

Key facts

Who runs it
University of Pennsylvania
Where
Philadelphia, United StatesSee the site
Trial code
Status
Completed
People taking part
133 people enrolled
Started
3 Jun 2020
Ended
10 May 2024
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Hypoglossal Nerve Stimulation
Record updated
21 January 2026

Who can take part

Age
22 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 13 criteriaShow less

Other criteria

  • Study A Inclusion Criteria:
  • Scheduled to undergo DISE as part of routine clinical standard of care; Study B Inclusion Criteria:
  • Adults (≥ 22yrs) willing and capable of providing informed consent
  • Implanted with the MRI-conditional Inspire hypoglossal nerve stimulator (Model 3028 or later)
  • Compliant with Inspire therapy (> 20 hours/week over 2+ weeks) as a standalone treatment for sleep-disordered breathing
  • Inspire remote model 2500 or later; Study B Exclusion Criteria:
  • MRI contraindications (claustrophobia, ferromagnetic implants/foreign bodies, etc.)
  • Inspire Implant Model 3024
  • Inspire Remote Model 3032
  • Patients who have fallen asleep while during resulting in an accident or "near miss" accident within 1 year prior to device implantation
  • Inability to sleep in the supine position (by self-report)
  • History of severe difficulty initiating or maintaining sleep in the laboratory
  • Pregnant women

Where in United States

  • Pennsylvania HospitalPhiladelphia, United States

About the trial

What the trial wants to find out

The current study is designed to examine underlying mechanisms of action of lingual muscles in the maintenance of airway patency during sleep. The investigators' major hypothesis is that specific tongue muscles are responsible for relieving upper airway obstruction during sleep.

The 3 groups in the trial

  • Study A - Functional Phenotyping during DISENo study treatment, for comparison

    Participants with diagnosed OSA undergo Drug-Induced Sleep Endoscopy (DISE) to characterize determinants of upper airway obstruction using CPAP and pharyngeal manometry. Jaw thrust and other positional maneuvers are performed during DISE as part of routine clinical standard of care.

  • Study B - HGNS RespondersTreatment being tested

    Participants with implanted Inspire HGNS devices undergo DISE and overnight polysomnography to assess upper airway responses with and without HGNS stimulation. CPAP titration is performed during DISE. Upper airway MRI and tongue force assessments are also conducted. Response was defined by a ≥ 50% reduction in AHI with stimulation.

    Treatment: Hypoglossal Nerve Stimulation

  • Study B - HGNS NonrespondersTreatment being tested

    Participants with implanted Inspire HGNS devices undergo DISE and overnight polysomnography to assess upper airway responses with and without HGNS stimulation. CPAP titration is performed during DISE. Upper airway MRI and tongue force assessments are also conducted. Nonresponse was defined by a \< 50% reduction in AHI with stimulation.

    Treatment: Hypoglossal Nerve Stimulation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Characterizing Mechanisms of Upper Airway Obstruction During Drug-Induced Sleep Endoscopy (DISE)
Record updated
21 January 2026